Barer & Son Capital
Overview
Barer & Son Capital is a venture capital firm founded in 2017 that invests in the healthcare and life science sectors, with a focus on early-stage biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AsclepiX Therapeutics | Jun 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Barer & Son Capital based?
Barer & Son Capital is headquartered in Mendham, New Jersey, United States.
When was Barer & Son Capital founded?
Barer & Son Capital was founded in 2017.
How many portfolio companies does Barer & Son Capital have?
Barer & Son Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Barer & Son Capital's portfolio?
Portfolio companies visible on Caplight include AsclepiX Therapeutics.
What was Barer & Son Capital's most recent investment shown here?
Barer & Son Capital's most recent investment in this portfolio sample was in AsclepiX Therapeutics in 2020.
What sectors does Barer & Son Capital focus on?
Barer & Son Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Barer & Son Capital focus on?
Stage focus information for Barer & Son Capital is not publicly available.